Boston Scientific to Acquire Nalu Medical for $533 Million to Expand Chronic Pain Portfolio with Innovative Miniature Neurostimulation System

Boston Scientific Corporation Announces Collaboration withNalu MedicalReached a final acquisition agreement, Boston Scientific to acquire for $600 millionNalu Medical. Since Boston Scientific had already invested in 2017Nalu Medical, therefore, Boston Scientific only needs to payApproximately $533 million can complete the acquisition.

Executive Evaluation

"Peripheral nerve stimulation is an exciting field with a large number of unmet patient needs. Adding the highly differentiated Nalu Medical technology complements our existing therapies—including spinal cord stimulation, basivertebral nerve ablation, and radiofrequency ablation—enabling us to offer advanced pain relief solutions to a broader patient population."

---Jim Cassidy  President of Boston Scientific's Neuromodulation Business

Nalu MedicalTheMicro Chronic Pain StimulatorNaluApproved by the FDA for marketing in 2019.NaluProven its excellent clinical outcomes in multiple clinical studies. For instance, inIn the Nalu COMFORT TrialShowed significant and lasting pain relief effects

• 87% of patients experienced 50% or more pain relief;
• Average pain reduction of 69%;
• 95% of patients reported overall improvement;
• 78% of patients reported a reduction in depressive symptoms;
• 73% of patients reported a reduction in disability rate;
• 70% of patients reported an improvement in quality of life.

Excellent clinical outcomes and unique technology have attracted significant capital attention. In September this yearNalu MedicalAlso received a $50 million investment from Trinity Capital, andAnd also attractRaymond W. Cohen, former founder and CEO of Axonics, joins (as Chairman of the Board, PS Boston Scientific$3.7 Billion AcquisitionAxonics). For Boston Scientific, it needs to acquire in time, otherwise the price will increase. In additionNaluThe market feedback has been very positive, with double-digit rapid growth every year since its launch in 2019. Boston Scientific Corporation forecasts this yearNalu Medical's sales will exceed $60 million, with annual growth surpassing 25% next year. Once integrated into Boston Scientific, its sales volume will rapidly increase under the strong promotion of Boston Scientific’s powerful sales team.

Here, we have to admire Boston Scientific's BD. They always pay attention to these innovative companies in the early stages and make arrangements ahead of time. As a result, Boston Scientific can acquire them at very low prices, rather than spending hundreds of billions like Johnson & Johnson. Moreover, Boston Scientific's small-scale acquisitions are no less effective.Billions of USD Mergers and Acquisitions (e.g., recent spending$295 million, or no more than $400 million including milestones）。

Nalu

NaluByA fully functional, battery-free, miniature implantable pulse generator (IPG), lead wire, therapy disc, and a remotely controllable APP.Micro ImplantablePulse GeneratorImplantable Pulse Generator (IPG)By externalThe therapeutic disc worn is wirelessly powered and throughAPPPerform remote control.

• Smaller, Less Invasive Implants: 27 Times Smaller Than the Largest Commercially Available Implantable Pulse Generator (IPG).
• Battery-Free Miniature IPG: Powered externally through a replaceable, wearable therapy disc, eliminating the need for an implanted battery and battery replacement surgery.

• Upgrade Without Surgery: Software can be wirelessly upgraded without surgery.

• Long-lasting use: Expected service life of 18 years for the long-term treatment of chronic intractable pain.

Nalu Medical Demonstration